Efficacy of pamidronate in breast cancer with bone metastases: A randomized double-blind placebo controlled multicenter study

Acta Oncologica

Volumn 35, Issue SUPPL. 5, 1996, Pages 73-74

  Hultborn, R ^a,e   Gundersen, S ^b   Ryden S ^a   Holmberg, E ^c   Carstensen, J ^a   Wallgren, U B ^a   Kilany, S ^d  

^a Department of Oncology ^*

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Centre of Oncology   (Sweden)

^d NOVARTIS PHARMA AG   (Switzerland)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID; PLACEBO;

ADULT; AGED; BONE METASTASIS; BREAST CANCER; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL;

BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; OSTEOLYSIS; PAIN; QUALITY OF LIFE;

EID: 0030483518     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609083974     Document Type: Article

References (4)

1. Elomaa I, Blomqvist C, Gröhn P, et al. Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. Lancet 1983; 22: 146-149.
2. Paterson AHG, Powles TJ, Kanis JA, McCloskey E, Hansson J, Ashley S. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 1993; 11: 59-65.
3. van Holten-Verzantvoort ATM, Kroon HM, Bijvoet OLM, et al. Palliative pamidronate treatment in patients with bone metastases from breast cancer. J Clin Oncol 1993; 11(3): 491-498.
4. Conte PF, Giannessi PG, Latreille J, et al. Delayed progression of bone metastases with pamidronate therapy in breast cancer patients.: A randomized, multicenter phase III trial. Annals of Oncol 1994; 5, suppl: 7: S41-S44.